CompoAtlas

Santé des yeux avec astaxanthine

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
3,3'-Dihydroxy-4,4'-diketo-bêta-carotène9 mgNot calculated
Mélange de concentré de tocophérol

Source : Helianthus annuus - Graine

75 mgNot calculated
Lutéine

Source : Tagetes erecta - Oléorésine (herbe en fleurs)

15 mgNot calculated
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Source : Tagetes erecta - Oléorésine (herbe en fleurs)

0.7 mgNot calculated

Non-medicinal ingredients

Triglycérides à chaîne moyenne, Hypromellose, farine de riz, Dextrine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Aide à améliorer la densité optique du pigment maculaire. Aide à préserver la vision/la santé des yeux dans certaines conditions (associées au dommage par le soleil) telles que les cataractes et la dégénérescence maculaire reliée à l'âge. Aide à réduire le risque de développer des cataractes. Source d'antioxydants/Fournit des antioxydants (pour le maintien d'une bonne santé). Source d'antioxydants/Fournit des antioxydants pour le maintien de la santé oculaire/des yeux. Source d'(un) antioxydant(s)/Fournit (un) (des) antioxydant(s) qui aide(nt) à combattre/à protéger (les cellules) contre/à réduire (les effets oxydatifs des/les dommages oxydatifs causés par/les dommages cellulaires causés par) les radicaux libres. Aide à réduire la fatigue oculaire (asthénopie).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
MJ Nutra
NPN or DIN-HM
80145734
Status
Active licence
Licence date
27 November 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80145734

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Santé des yeux avec astaxanthine (MJ Nutra): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80145734-sante-des-yeux-avec-astaxanthine, updated 27 November 2025.

Enter to analyse, Shift+Enter for a new line